12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, Cancer Research U.K., University of Manchester deal

Cancer Research Technology Ltd., the commercialization arm of Cancer Research U.K., and the university partnered with GlaxoSmithKline to develop cancer drugs targeting an undisclosed protein involved in epigenetic regulation....

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >